LFSC ETF
F/m Emerald Life Sciences Innovation ETF
LFSC ETF Overview
LFSC ETF (F/m Emerald Life Sciences Innovation ETF) is managed by Emerald ETF with $126.1M in net assets. LFSC expense ratio is 0.54%, holding 40 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2024-10-30.
LFSC performance shows a YTD return of 24.63%. The 1-year return is 88.35%.
LFSC top holdings include Travere Therapeutics Inc (8.7%), Corcept Therapeutics Incorporated (6.7%), Spyre Therapeutics Inc (6.7%), Livanova Plc Ordinary Shares (6.6%), Cogent Biosciences Inc (6.5%). Go to all LFSC holdings, LFSC sectors, or LFSC dividends.
LFSC can be compared against other funds. Use LFSC overlap to find shared positions, or LFSC vs another fund for a side-by-side view. LFSC alternatives are available via the screener, along with tax-loss harvesting opportunities.